These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34900856)

  • 1. Biopsy or Biomarker? Children With Minimal Change Disease Have a Distinct Profile of Urinary Epidermal Growth Factor.
    Lodeweyckx N; Wouters K; Ledeganck KJ; Trouet D
    Front Pediatr; 2021; 9():727954. PubMed ID: 34900856
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome.
    Gipson DS; Trachtman H; Waldo A; Gibson KL; Eddy S; Dell KM; Srivastava T; Lemley KV; Greenbaum LA; Hingorani S; Meyers KE; Kaskel FJ; Reidy KJ; Sethna CB; Tran CL; Wang CS; Tuttle KR; Oh G; Neu AM; Brown E; Lin JJ; Yee JL; Roth TM; Troost JP; Gillespie BW; Sampson MG; Kretzler M; Ju W
    Kidney Int Rep; 2020 Apr; 5(4):414-425. PubMed ID: 32280839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
    Chehade H; Parvex P; Poncet A; Werner D; Mosig D; Cachat F; Girardin E
    Pediatr Nephrol; 2013 Dec; 28(12):2299-306. PubMed ID: 23949592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children.
    Li B; Zhang Y; Wang F; Nair V; Ding F; Xiao H; Yao Y; Kretzler M; Ju W; Ding J
    Pediatr Nephrol; 2018 Oct; 33(10):1731-1739. PubMed ID: 29948307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete Remission in the Nephrotic Syndrome Study Network.
    Gipson DS; Troost JP; Lafayette RA; Hladunewich MA; Trachtman H; Gadegbeku CA; Sedor JR; Holzman LB; Moxey-Mims MM; Perumal K; Kaskel FJ; Nelson PJ; Tuttle KR; Bagnasco SM; Hogan MC; Dell KM; Appel GB; Lieske JC; Ilori TO; Sethna CB; Fervenza FC; Hogan SL; Nachman PH; Rosenberg AZ; Greenbaum LA; Meyers KE; Hewitt SM; Choi MJ; Kopp JB; Zhdanova O; Hodgin JB; Johnstone DB; Adler SG; Avila-Casado C; Neu AM; Hingorani SR; Lemley KV; Nast CC; Brady TM; Barisoni-Thomas L; Fornoni A; Jennette JC; Cattran DC; Palmer MB; Gibson KL; Reich HN; Mokrzycki MH; Sambandam KK; Zilleruelo GE; Licht C; Sampson MG; Song P; Mariani LH; Kretzler M
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):81-9. PubMed ID: 26656320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C.
    Conti M; Moutereau S; Esmilaire L; Desbene C; Lallali K; Devanlay M; Durrbach A; Manivet P; Eschwège P; Loric S
    Clin Chem Lab Med; 2009; 47(12):1553-6. PubMed ID: 19877765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy.
    Zhou J; Sun S; Zhang D; Mao J; Xiao H; Yao Y; Wang F; Yu L; Liu L; Feng C; Li C; Su B; Zhang H; Liu X; Xu K; Ju W; Zhong X; Ding J
    Pediatr Res; 2023 Aug; 94(2):747-755. PubMed ID: 36864281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM; Ezzat DA; Doudar NA; Adel M
    Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and epidermal growth factor as noninvasive biomarkers of progression in chronic glomerulonephritis.
    Idasiak-Piechocka I; Miedziaszczyk M; Woźniak A; Pawliczak E; Kaczmarek E; Oko A
    Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1267-C1275. PubMed ID: 37721004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.
    Mariani LH; Martini S; Barisoni L; Canetta PA; Troost JP; Hodgin JB; Palmer M; Rosenberg AZ; Lemley KV; Chien HP; Zee J; Smith A; Appel GB; Trachtman H; Hewitt SM; Kretzler M; Bagnasco SM
    Nephrol Dial Transplant; 2018 Feb; 33(2):310-318. PubMed ID: 28339906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary CD80 and Serum suPAR as Biomarkers of Glomerular Disease among Adults in Brazil.
    Zen RC; Dominguez WV; Braga I; Dos Reis LM; Jorge LB; Yu L; Woronik V; Dias CB
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alport syndrome: the effects of spironolactone on proteinuria and urinary TGF-β1.
    Giani M; Mastrangelo A; Villa R; Turolo S; Marra G; Tirelli AS; Hopfer H; Edefonti A
    Pediatr Nephrol; 2013 Sep; 28(9):1837-42. PubMed ID: 23748277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity-related glomerulopathy: an emerging epidemic.
    Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
    Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
    Pérez V; Ibernón M; López D; Pastor MC; Navarro M; Navarro-Muñoz M; Bonet J; Romero R
    PLoS One; 2014; 9(1):e87731. PubMed ID: 24498182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Epidermal Growth Factor: A Promising "Next Generation" Biomarker in Kidney Disease.
    Cortvrindt C; Speeckaert R; Delanghe JR; Speeckaert MM
    Am J Nephrol; 2022; 53(5):372-387. PubMed ID: 35537382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Azukaitis K; Ju W; Kirchner M; Nair V; Smith M; Fang Z; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Yalcinkaya F; Paripovic D; Harambat J; Cakar N; Alpay H; Lugani F; Mencarelli F; Civilibal M; Erdogan H; Gellermann J; Vidal E; Tabel Y; Gimpel C; Ertan P; Yavascan O; Melk A; Querfeld U; Wühl E; Kretzler M; Schaefer F; ;
    Kidney Int; 2019 Jul; 96(1):214-221. PubMed ID: 31005273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.